查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056811

用於混合模式層析法的樹脂的全球市場

Mixed Mode Chromatography Resins
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 178 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2032 年，全球混合模式層析法樹脂市場規模將達到 1.537 億美元。

全球混合模式層析法樹脂市場規模預計在2025年為9,620萬美元，在2025年至2032年的分析期間內將以6.9%的複合年成長率成長，到2032年達到1.537億美元。本報告分析的細分市場之一「離子交換-疏水法」預計將以7.4%的複合年成長率成長，並在分析期間結束時達到8000萬美元。 「羥磷石灰法」細分市場預計在整個分析期間也將以6.6%的複合年成長率成長。

美國市場規模估計為 2,810 萬美元，而中國市場預計將以 6.6% 的複合年成長率成長。

美國混合模式層析法樹脂市場預計2025年將達到2,810萬美元。作為世界第二大經濟體，中國市場預計在2025年至2032年的分析期間將以6.6%的複合年成長率成長，到2032年市場規模將達到2,720萬美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期內將分別以6.4%和5.9%的複合年成長率成長。在歐洲，德國預計將以約5.6%的複合年成長率成長。

全球混合模式層析法市場—關鍵趨勢與促進因素概述

混合模式層析法如何改變生物分子的分離？

混合模式層析法樹脂是專門用於分離和純化生物分子（例如蛋白質、抗體和核酸）的專用材料。這些樹脂結合了多種相互作用模式，包括離子交換、疏水交互作用和親和層析法，從而提高純化過程的效率和選擇性。混合模式層析法技術在生物製藥產業正廣泛應用，該產業對高純度、低成本的複雜生物製藥分離技術的需求日益成長。由於其多功能性，混合模式層析法樹脂適用於多種應用，包括單株抗體、重組蛋白和疫苗組分的純化。它們尤其適用於純化那些難以以傳統單一模式層析法技術分離的生物分子。由於只需一步即可實現高解析度和高選擇性，因此可以顯著減少所需的純化步驟，從而縮短處理時間並降低成本。

哪些創新正在塑造混合模式層析法樹脂市場？

推動混合模式層析法樹脂發展的創新包括樹脂設計的進步、先進的配體化學以及新型材料的引入。各公司正致力於開發具有更高結合容量和更優異目標分子選擇性的樹脂。新型配體的引入，使其能夠在更寬的pH範圍和離子強度條件下發揮作用，從而拓展了混合模式層析法在各類生物分子中的應用。自動化和製程控制也加速了混合模式層析法在工業規模純化的應用。自動化層析法系統可以進行編程，以最佳化特定樹脂的程式參數，從而確保分離的一致性和高品質。採用混合模式樹脂的連續層析法技術正逐漸成為生物製造領域的趨勢，能夠實現更有效率的純化流程。

市場區隔如何定義混合模式層析法樹脂的成長？

這些技術包括疏水交互作用、離子交換色譜和多模態層析法，其中多模態層析法是應用最廣泛的技術之一，因為它能夠結合不同的相互作用機制來提高選擇性。應用領域包括抗體純化和蛋白質純化，由於治療應用中對單株抗體的需求不斷成長，抗體純化佔了較大的市場佔有率。混合模式層析法樹脂的終端使用者包括生物製藥公司、研究機構和合約研究組織（CRO）。生物製藥公司是最大的終端用戶群體，這主要源於他們對改進純化製程和降低生產成本的需求。從區域來看，北美市場佔據領先地位，這得益於生物製藥公司數量眾多以及先進的研究基礎設施。同時，由於生物製藥領域的投資和研究活動不斷增加，亞太地區也正在經歷快速成長。

哪些因素推動了混合模式層析法樹脂市場的成長？

混合模式層析法樹脂市場的成長受到多種因素的驅動，包括生物製藥需求的不斷成長、對經濟高效的純化技術的需求以及樹脂技術的進步。隨著生物製藥產業的擴張，對用於生產治療性蛋白質、抗體和疫苗的高純度分離技術的需求日益成長。混合模式層析法因其簡化純化流程並減少所需步驟，對尋求最佳化生產成本的製造商極具吸引力。此外，新型樹脂的開發（這些樹脂具有更強的結合能力）以及層析法製程自動化的引入，也進一步推動了市場成長。

部分：

技術（離子交換 - 疏水性、羥基磷灰石、其他技術），應用（多株抗體、非抗體蛋白、單株抗體）

大公司

  • Bio-Rad Laboratories
  • Bio-Works Company Ltd.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • JSR Micro Inc.
  • Kaneka Corporation
  • Knauer Gmbh
  • Life Technology Corporation
  • Merck
  • Pall Corporation
  • Purolite Corporation
  • Sepragen Corporation
  • Thermo Fisher Scientific
  • Tosoh Corporation

目錄

第1章：調查方法

第2章執行摘要

  • 市場概覽
  • 大公司
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP22304

Global Mixed Mode Chromatography Resins Market to Reach US$153.7 Million by 2032

The global market for Mixed Mode Chromatography Resins estimated at US$96.2 Million in the year 2025, is expected to reach US$153.7 Million by 2032, growing at a CAGR of 6.9% over the analysis period 2025-2032. Ion Exchange - Hydrophobic Technique, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$80.0 Million by the end of the analysis period. Growth in the Hydroxyapatite Technique segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$28.1 Million While China is Forecast to Grow at 6.6% CAGR

The Mixed Mode Chromatography Resins market in the U.S. is estimated at US$28.1 Million in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$27.2 Million by the year 2032 trailing a CAGR of 6.6% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Mixed Mode Chromatography Resins Market - Key Trends and Drivers Summarized

How Is Mixed Mode Chromatography Revolutionizing Biomolecule Separation?

Mixed mode chromatography resins are specialized materials used in the separation and purification of biomolecules, such as proteins, antibodies, and nucleic acids. These resins utilize a combination of different interaction modes, such as ion exchange, hydrophobic interaction, and affinity chromatography, to improve the efficiency and selectivity of the purification process. The adoption of mixed mode chromatography is gaining traction in the biopharmaceutical industry, where there is a growing need for high-purity and cost-effective separation techniques for complex biological products. The versatility of mixed mode chromatography resins makes them suitable for various applications, including the purification of monoclonal antibodies, recombinant proteins, and vaccine components. They are particularly valuable for purifying biomolecules that are challenging to separate using traditional single-mode chromatography techniques. The ability to achieve high resolution and selectivity in a single step can significantly reduce the number of purification steps required, thereby saving time and reducing costs.

What Innovations Are Shaping the Mixed Mode Chromatography Resins Market?

Several innovations are driving the development of mixed mode chromatography resins, including advances in resin design, enhanced ligand chemistry, and the incorporation of novel materials. Companies are focusing on developing resins that offer higher binding capacities and better selectivity for target molecules. The introduction of new ligands that can operate under a wider range of pH conditions and ionic strengths is expanding the applicability of mixed mode chromatography across different types of biomolecules. Automation and process control are also enhancing the adoption of mixed mode chromatography in industrial-scale purification. Automated chromatography systems can be programmed to optimize process parameters for specific resins, ensuring consistent and high-quality separations. The integration of continuous chromatography techniques, where mixed mode resins are used in continuous processing formats, is emerging as a trend in biomanufacturing, allowing for more efficient purification workflows.

How Do Market Segments Define the Growth of Mixed Mode Chromatography Resins?

Techniques include hydrophobic interaction, ion exchange, and multimodal chromatography, with multimodal chromatography being one of the most widely used due to its ability to combine different interaction mechanisms for improved selectivity. Applications encompass antibody purification, protein purification, and others, with antibody purification accounting for a significant market share due to the growing demand for monoclonal antibodies in therapeutic applications. End-users of mixed mode chromatography resins include biopharmaceutical companies, research institutions, and contract research organizations (CROs). Biopharmaceutical companies represent the largest end-user segment, driven by the need to improve purification processes and reduce manufacturing costs. Geographically, North America leads the market due to a strong presence of biopharmaceutical companies and advanced research infrastructure, while Asia-Pacific is experiencing rapid growth owing to increasing biopharmaceutical investments and research activities.

What Factors Are Driving the Growth in the Mixed Mode Chromatography Resins Market?

The growth in the mixed mode chromatography resins market is driven by several factors, including the increasing demand for biopharmaceuticals, the need for cost-effective purification techniques, and advancements in resin technology. As the biopharmaceutical industry expands, there is a growing need for high-purity separation techniques to produce therapeutic proteins, antibodies, and vaccines. The ability of mixed mode chromatography to simplify purification workflows and reduce the number of steps required is appealing to manufacturers looking to optimize production costs. Additionally, the development of novel resins with enhanced binding capacities and the integration of automation in chromatography processes are further propelling market growth.

SCOPE OF STUDY:

The report analyzes the Mixed Mode Chromatography Resins market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Ion Exchange - Hydrophobic, Hydroxyapatite, Other Techniques); Application (Polyclonal Antibodies, Non-Antibody Protein, Monoclonal Antibodies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

SELECT PLAYERS -

  • Bio-Rad Laboratories
  • Bio-Works Company Ltd.
  • Danaher Corporation
  • GE Healthcare Life Sciences
  • JSR Micro Inc.
  • Kaneka Corporation
  • Knauer Gmbh
  • Life Technology Corporation
  • Merck
  • Pall Corporation
  • Purolite Corporation
  • Sepragen Corporation
  • Thermo Fisher Scientific
  • Tosoh Corporation

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 2,264 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Mixed Mode Chromatography Resins - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Resolution Separation Techniques Spurs Growth in Mixed Mode Chromatography Resins Market
    • Technological Advancements in Resin Design and Functionalization Strengthen Business Case for Adoption
    • Growing Focus on Biopharmaceuticals and Protein Purification Expands Addressable Market for Chromatography Resins
    • Expansion of Mixed Mode Chromatography in Monoclonal Antibody (mAb) Production Fuels Market Growth
    • Increasing Adoption of Chromatography Resins in Viral and Gene Therapy Applications Expands Market Opportunities
    • Technological Innovations in High-Capacity and Selective Resins Propel Market Expansion
    • Rising Focus on Enhancing Purity and Yield in Downstream Processing Drives Demand for Chromatography Resins
    • Growing Use of Mixed Mode Chromatography in Analytical and Preparative Applications Expands Market Potential
    • Technological Advancements in Single-Use and Disposable Chromatography Systems Propel Market Growth
    • Rising Demand for Chromatography Resins in Continuous Processing and Perfusion Systems Strengthens Global Market
    • Expansion of Mixed Mode Chromatography in Food and Beverage Testing and Quality Control Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 2: World Historic Review for Mixed Mode Chromatography Resins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 3: World 13-Year Perspective for Mixed Mode Chromatography Resins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
    • TABLE 4: World Recent Past, Current & Future Analysis for Ion Exchange - Hydrophobic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 5: World Historic Review for Ion Exchange - Hydrophobic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 6: World 13-Year Perspective for Ion Exchange - Hydrophobic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 7: World Recent Past, Current & Future Analysis for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 8: World Historic Review for Hydroxyapatite by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 9: World 13-Year Perspective for Hydroxyapatite by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 11: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 12: World 13-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 13: World Recent Past, Current & Future Analysis for Polyclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 14: World Historic Review for Polyclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 15: World 13-Year Perspective for Polyclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 16: World Recent Past, Current & Future Analysis for Non-Antibody Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 17: World Historic Review for Non-Antibody Protein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 18: World 13-Year Perspective for Non-Antibody Protein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 19: World Recent Past, Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 20: World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 21: World 13-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
    • TABLE 22: World Mixed Mode Chromatography Resins Market Analysis of Annual Sales in US$ for Years 2020 through 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 24: USA Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 25: USA 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 26: USA Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 27: USA Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 28: USA 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 30: Canada Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 31: Canada 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 33: Canada Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 34: Canada 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • JAPAN
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 36: Japan Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 37: Japan 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Japan Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 40: Japan 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • CHINA
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 42: China Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 43: China 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 44: China Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 45: China Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 46: China 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • EUROPE
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2025 through 2032 and % CAGR
    • TABLE 48: Europe Historic Review for Mixed Mode Chromatography Resins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 49: Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 51: Europe Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 52: Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Europe Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 55: Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • FRANCE
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 57: France Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 58: France 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 59: France Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 60: France Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 61: France 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • GERMANY
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Germany Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 64: Germany 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Germany Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 67: Germany 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Italy Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 70: Italy 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Italy Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 73: Italy 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 75: UK Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 76: UK 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 77: UK Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 78: UK Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 79: UK 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 82: Rest of Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 85: Rest of Europe 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Mixed Mode Chromatography Resins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 88: Asia-Pacific 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 91: Asia-Pacific 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Rest of World Historic Review for Mixed Mode Chromatography Resins by Technique - Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 94: Rest of World 13-Year Perspective for Mixed Mode Chromatography Resins by Technique - Percentage Breakdown of Value Sales for Ion Exchange - Hydrophobic, Hydroxyapatite and Other Techniques for the Years 2020, 2026 & 2032
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies - Independent Analysis of Annual Sales in US$ for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Rest of World Historic Review for Mixed Mode Chromatography Resins by Application - Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2024 and % CAGR
    • TABLE 97: Rest of World 13-Year Perspective for Mixed Mode Chromatography Resins by Application - Percentage Breakdown of Value Sales for Polyclonal Antibodies, Non-Antibody Protein and Monoclonal Antibodies for the Years 2020, 2026 & 2032

IV. COMPETITION